• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于甲状腺恶性肿瘤不同发生率的 Bethesda 分类系统Ⅲ类(AUS/FLUS)中核异型和结构异型的分离建议

A Proposal for Separation of Nuclear Atypia and Architectural Atypia in Bethesda Category III (AUS/FLUS) Based on Differing Rates of Thyroid Malignancy.

机构信息

Department of Pathology, University of Chicago, Chicago, IL.

Centegra Health System, McHenry, IL.

出版信息

Am J Clin Pathol. 2019 Jan 1;151(1):86-94. doi: 10.1093/ajcp/aqy109.

DOI:10.1093/ajcp/aqy109
PMID:30212867
Abstract

OBJECTIVES

Bethesda category III (atypia of undetermined significance/follicular lesion of undetermined significance) includes sparsely cellular specimens with nuclear atypia (3N) and/or architectural atypia (3A). This study investigates whether the two types of atypia have different rates of malignancy (ROMs).

METHODS

Cytologic and histologic diagnoses of resected thyroid nodules were recorded. ROM was calculated for all Bethesda categories and for 3N and 3A subcategories. Possible noninvasive follicular thyroid neoplasms with papillary-like nuclear features were reviewed and removed from malignancies, and ROM was recalculated.

RESULTS

A total of 1,396 nodules were included. ROM of 3N (33.3%-26.0%) was higher than 3A (7.7%-5.0%) (P < .0001) and was similar to suspicious for follicular neoplasm (25.0%-20.3%) (P = .3). ROM of 3A approached benign (2.4%-1.5%) (P = .02).

CONCLUSIONS

Strong consideration should be given to separating 3N (nuclear atypia with higher risk for papillary thyroid carcinoma) from 3A (architectural atypia with higher chance of being benign) to convey different ROMs.

摘要

目的

贝塞斯达分类 III 级(意义不明确的不典型/意义不明确的滤泡性病变)包括核异型性(3N)和/或结构异型性(3A)稀疏的细胞标本。本研究旨在探讨这两种异型性的恶性程度(ROM)是否不同。

方法

记录切除甲状腺结节的细胞学和组织学诊断。计算所有贝塞斯达分类以及 3N 和 3A 亚类的 ROM。对具有乳头状核特征的可能无侵袭性滤泡性甲状腺肿瘤进行了回顾,并从恶性肿瘤中去除,重新计算了 ROM。

结果

共纳入 1396 个结节。3N(33.3%-26.0%)的 ROM 高于 3A(7.7%-5.0%)(P<0.0001),与滤泡性肿瘤可疑(25.0%-20.3%)相似(P=0.3)。3A 的 ROM 接近良性(2.4%-1.5%)(P=0.02)。

结论

强烈建议将 3N(具有更高的甲状腺乳头状癌风险的核异型性)与 3A(具有更高良性可能性的结构异型性)分开,以传达不同的 ROM。

相似文献

1
A Proposal for Separation of Nuclear Atypia and Architectural Atypia in Bethesda Category III (AUS/FLUS) Based on Differing Rates of Thyroid Malignancy.基于甲状腺恶性肿瘤不同发生率的 Bethesda 分类系统Ⅲ类(AUS/FLUS)中核异型和结构异型的分离建议
Am J Clin Pathol. 2019 Jan 1;151(1):86-94. doi: 10.1093/ajcp/aqy109.
2
Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology.根据甲状腺细胞病理学报告的贝塞斯达系统中意义未明的非典型性或意义未明的滤泡性病变(AUS/FLUS)类别的亚分类情况,发生恶性肿瘤的风险。
Cytopathology. 2017 Feb;28(1):65-73. doi: 10.1111/cyt.12352. Epub 2016 Jun 1.
3
Two-tier subclassification of the Bethesda category III (atypia of undetermined significance/follicular lesion of undetermined significance) in thyroid cytology.甲状腺细胞学中 Bethesda 分类 III 级(意义不明确的非典型/意义不明确的滤泡性病变)的双层亚分类。
Diagn Cytopathol. 2024 Mar;52(3):156-162. doi: 10.1002/dc.25261. Epub 2023 Dec 14.
4
Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.在“意义不明确的非典型性/意义不明确的滤泡性病变”这一贝塞斯达分类中,甲状腺细胞学检查——核非典型性与结构非典型性的恶性率存在显著差异。
Cancer Cytopathol. 2017 Apr;125(4):245-256. doi: 10.1002/cncy.21823. Epub 2017 Feb 13.
5
Impact of the modification of the diagnostic criteria in the 2017 Bethesda System for Reporting Thyroid Cytopathology: a report of a single institution in Japan.2017年《甲状腺细胞病理学报告贝塞斯达系统》诊断标准修订的影响:日本一家机构的报告
Endocr J. 2018 Dec 28;65(12):1193-1198. doi: 10.1507/endocrj.EJ18-0290. Epub 2018 Oct 3.
6
Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.提出具有乳头状核特征的非浸润性滤泡性甲状腺肿瘤(NIFTP)的细胞学诊断:不典型和可疑结节的回顾性分析。
Cancer Cytopathol. 2018 Feb;126(2):86-93. doi: 10.1002/cncy.21922. Epub 2017 Sep 15.
7
High risk of malignancy in cases with atypia of undetermined significance on fine needle aspiration of thyroid nodules even after exclusion of NIFTP.即使排除了非典型滤泡性肿瘤/嗜酸细胞肿瘤(NIFTP),甲状腺结节细针抽吸细胞学检查为意义不明确的不典型病变(AUS)的病例仍有较高的恶性肿瘤风险。
Diagn Cytopathol. 2020 Nov;48(11):986-997. doi: 10.1002/dc.24533. Epub 2020 Aug 3.
8
Prevalence and associated malignancy of Bethesda category III cytologies of thyroid nodules assigned to the "cytological atypia" or "architectural atypia" groups.归类于“细胞非典型性”或“结构非典型性”组别的甲状腺结节的贝塞斯达III类细胞学检查结果的患病率及相关恶性肿瘤情况
Endocrinol Diabetes Nutr (Engl Ed). 2018 Dec;65(10):577-583. doi: 10.1016/j.endinu.2018.07.001. Epub 2018 Sep 24.
9
Risk of malignancy in Thyroid "Atypia of undetermined significance/Follicular lesion of undetermined significance" and its subcategories - A 5-year experience.甲状腺“意义不明确的非典型性/意义不明确的滤泡性病变”及其亚类的恶性风险——一项5年的经验
Indian J Pathol Microbiol. 2019 Oct-Dec;62(4):544-548. doi: 10.4103/IJPM.IJPM_319_19.
10
An institutional experience: A retrospective analysis of the effect of transitioning from follicular lesion of undetermined significance to atypia of undetermined significance with subclassified atypia on interobserver concordance, rates of neoplasia, and rates of malignancy.机构经验:回顾性分析从滤泡性意义未明病变到意义未明不典型增生并细分不典型增生对观察者间一致性、肿瘤发生率和恶性率的影响。
Diagn Cytopathol. 2021 Jan;49(1):31-38. doi: 10.1002/dc.24611. Epub 2020 Sep 16.

引用本文的文献

1
Risk of malignancy in thyroid nodules Bethesda III sub classification into nuclear atypia and architectural atypia. .甲状腺结节中恶性风险的贝塞斯达Ⅲ级再细分为核异型性和结构异型性。
Saudi Med J. 2025 Apr;46(4):425-428. doi: 10.15537/smj.2025.46.4.202040805.
2
UTILITY OF THE 2023 BETHESDA SYSTEM AUS SUBCATEGORIZATION ON THYROID ASPIRATES.2023年贝塞斯达系统对甲状腺细针穿刺抽吸物亚分类的实用性
Acta Endocrinol (Buchar). 2024 Jan-Mar;20(1):1-4. doi: 10.4183/aeb.2024.1. Epub 2024 Oct 3.
3
Performance of ACR TI-RADS and the Bethesda System in Predicting Risk of Malignancy in Thyroid Nodules at a Large Children's Hospital and a Comprehensive Review of the Pediatric Literature.
ACR TI-RADS和贝塞斯达系统在一家大型儿童医院预测甲状腺结节恶性风险中的表现及儿科文献综述
Cancers (Basel). 2023 Aug 4;15(15):3975. doi: 10.3390/cancers15153975.
4
Is Subdivision of Atypia of Undetermined Significance AUS/Follicular Lesion of Undetermined Significance Cases According to Detailed Nuclear Features Vital for Assessing the Risk of Malignancy?根据对评估恶性风险至关重要的详细核特征,对意义未明的非典型性/AUS/意义未明的滤泡性病变病例进行细分是否有必要?
J Cytol. 2020 Oct-Dec;37(4):204-209. doi: 10.4103/JOC.JOC_5_20. Epub 2020 Nov 6.
5
A Large Thyroid Fine Needle Aspiration Biopsy Cohort with Long-Term Population-Based Follow-Up.大甲状腺细针穿刺活检队列的长期基于人群的随访。
Thyroid. 2021 Jul;31(7):1086-1095. doi: 10.1089/thy.2020.0689. Epub 2021 Jan 29.
6
Usage and Diagnostic Yield of Fine-Needle Aspiration Cytology and Core Needle Biopsy in Thyroid Nodules: A Systematic Review and Meta-Analysis of Literature Published by Korean Authors.甲状腺结节细针穿刺细胞学检查和粗针活检的应用及诊断率:韩国作者发表文献的系统评价与荟萃分析
Clin Exp Otorhinolaryngol. 2021 Feb;14(1):116-130. doi: 10.21053/ceo.2020.00199. Epub 2020 Jun 20.
7
Validation of molecular biomarkers for preoperative diagnostics of human papillary thyroid carcinoma in fine needle aspirates.细针穿刺抽吸物中用于人乳头状甲状腺癌术前诊断的分子生物标志物的验证
Gland Surg. 2019 Aug;8(Suppl 2):S62-S76. doi: 10.21037/gs.2018.11.04.
8
Semiquantitative assessment of cytomorphologic features can predict mutation status of thyroid nodules with indeterminate cytologic diagnosis.半定量评估细胞学形态特征可预测细胞学诊断不确定的甲状腺结节的突变状态。
Hum Pathol. 2019 Nov;93:81-89. doi: 10.1016/j.humpath.2019.08.010. Epub 2019 Aug 19.
9
Thyroid cytopathology: updates and molecular testing.甲状腺细胞病理学:最新进展与分子检测
Pathologica. 2019 Jun;111(2):51-57. doi: 10.32074/1591-951X-10-19.